Hebrew University, US Scientists Find Clue To Mystery Of How Biological Clock Operates On 24-hour Cycle

How does our biological system know that it is supposed to operate on a 24-hour cycle? Scientists at the Hebrew University of Jerusalem have discovered that a tiny molecule holds the clue to the mystery. Human as well as most living organisms on earth possess circadian a (24-hour) life rhythm. This rhythm is generated from an internal clock that is located in the brain and regulates many bodily functions, including the sleep-wake cycle and eating. Tags: Insomnia Sleeping problems Insomnia information Sleepin

Startled Flies May Provide Insight Into ADHD

It seems obvious that naturally waking up from sleep and being startled by something in the environment are two very different emotional states. However, the neuroscience that underlies these different forms of arousal has, for the most part, remained a mystery. Now, new research published by Cell Press in the November 25 issue of the journal Neuron demonstrates that there are at least two completely separate and independent forms of arousal in fruit flies. Tags: Insomnia Sleeping problems Insomnia information Sleepin

Guests? Just Roll Out the Air

a href="http://www.nytimes.com/2009/11/26/garden/26roadtest.html?partner=rssnytemc=rss"img src="http://graphics8.nytimes.com/images/2009/11/25/garden/26roadtest/thumbStandard-v2.jpg" border="0" height="75" width="75" hspace="4" align="left"/aForsaking my own full-size mattress, I tested five air beds to find out how comfortable they really are. Tags: Insomnia Sleeping problems Insomnia information Sleepin

Guests? Just Roll Out the Air

Forsaking my own full-size mattress, I tested five air beds to find out how comfortable they really are. Tags: Insomnia Sleeping problems Insomnia information Sleepin

Insomnia Prevalent Among Cancer Patients Who Receive Chemotherapy

Three quarters of cancer patients and survivors treated with chemotherapy suffer insomnia or sleep disorders that often become chronic conditions, hindering patients' ability to fully recover, according to scientists at the University of Rochester Medical Center. A study of 823 cancer patients showed they experienced sleep troubles at nearly three times the rate of the general population. Tags: Insomnia Sleeping problems Insomnia information Sleepin

Falls Among Elderly And Sedatives, Mood-Altering Drugs Linked: UBC Study

Falls among elderly people are significantly associated with several classes of drugs, including sedatives often prescribed as sleep aids and medications used to treat mood disorders, according to a study led by a University of British Columbia expert in pharmaceutical outcomes research. The study, published Nov. 23 in the Archives of Internal Medicine, provides the latest quantitative evidence of the impact of certain classes of medication on falling among seniors. Tags: Insomnia Sleeping problems Insomnia information Sleepin

When Dreams Take Flight

a href="http://www.nytimes.com/2009/11/25/opinion/25fuller.html?partner=rssnytemc=rss"img src="http://graphics8.nytimes.com/images/2009/11/24/opinion/25oped/thumbStandard.jpg" border="0" height="75" width="75" hspace="4" align="left"/aOn a Thanksgiving Day flight, a tired attendant finds an unlikely spot to get some sleep. Tags: Insomnia Sleeping problems Insomnia information Sleepin

When Dreams Take Flight

On a Thanksgiving Day flight, a tired attendant finds an unlikely spot to get some sleep. Tags: Insomnia Sleeping problems Insomnia information Sleepin

Insomnia Is Common, Likely Under-Diagnosed Among People With Cancer Undergoing Chemotherapy

Researchers have found that 43 percent of patients undergoing chemotherapy for cancer in a clinical trial met the clinical criteria for insomnia syndrome and an additional 37 percent had insomnia symptoms, suggesting that the majority of patients (80 percent) suffer from sleep difficulties. This rate is approximately two to three times higher than that seen in the general population. Tags: Insomnia Sleeping problems Insomnia information Sleepin

Transcept Pharmaceuticals Scheduled To Meet With FDA To Discuss Intermezzo(R) Complete Response Letter

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo® (zolpidem tartrate sublingual tablet). As previously announced, the Complete Response Letter, received by Transcept on October 28, 2009, indicated that the FDA could not approve the NDA in its present form. Tags: Insomnia Sleeping problems Insomnia information Sleepin